RICTOR and neoplasm: To assess Rictor protein expression in these cancerous tissues, we employed Immunohistochemistry, revealing that 676 out of 1366 samples (49.5%) displayed Rictor immunoreactivity, specifically localized to the cytoplasm of the tumor cells, as depicted in the additional figure.